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Abstract
Introduction The purpose of this study was to evaluate the
safety and efficacy of the recently available flow diverter
“pipeline embolization device” (PED) for the treatment of
intracranial aneurysms and dissections.
Methods Eighty-eight consecutive patients underwent an
endovascular treatment of 101 intracranial aneurysms or
dissections using the PED between September 2009 and
January 2011. The targeted vessels include 79 (78%) in the
anterior circulation and 22 (22%) in the posterior circula-
tion. We treated 96 aneurysms and 5 vessel dissections.
Multiple devices were implanted in 67 lesions (66%).
Results One technical failure of the procedure was encoun-
tered. Immediate exclusion of the target lesion was not
observed. Angiographic follow-up examinations were carried
out in 80 patients (91%) with 90 lesions and revealed
complete cure of the target lesion(s) in 47 (52%), morpholog-
icalimprovement in32lesions (36%),and noimprovement in
11 lesions (12%). Six major complications were encountered:
one fatal aneurysm rupture, one acute and one delayed PED
thrombosis, and three hemorrhages in the dependent brain
parenchyma.
Conclusion Our experience reveals that the PED proce-
dure is technically straightforward for the treatment of
selected wide-necked saccular aneurysms, fusiform
aneurysms, remnants of aneurysms, aneurysms with a
high likelihood of failure with conventional endovascu-
lar techniques, and dissected vessels. While vessel
reconstruction, performed after dissection, is achieved
within days, remodeling of aneurysmal dilatations may
take several months. Dual platelet inhibition is obliga-
tory. Parenchymal bleeding into brain areas dependent
on the target vessel is uncommon.
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Introduction
Endovascular treatment has matured to a safe and effective
therapy in the management of intracranial aneurysms. In
saccular aneurysms with a well-defined neck, coil occlusion
can mostly be achieved without difficulty. In wide-necked
aneurysms, stent deployment or balloon remodeling may be
required in order to exclude the aneurysm with preservation
of the parent artery [1, 2].
The term “flow diversion” refers to the concept of
hemodynamic influence on an aneurysm by reducing both
inflow and outflow. Flow modification and reconstruction
of the parent artery with subsequent intraaneurysmal
thrombosis or “reverse remodeling” can, within certain
limits, be achieved by conventional porous stents and stent
grafts [3–5]. The main issues of stent grafts are their
stiffness and the unavoidable occlusion of all covered side
branches. The technique of telescoping porous stents may
work, but efficiency mostly remains unpredictable [6].
Flow diverters are stent-like endovascular implants
designed to alter the blood flow in an artery in a way that
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vessel and reduces inflow and outflow of an aneurysm
covered by the device. Flow diverters can be based on
braided or laser-cut metallic structures. The first flow
diverter commercially available was the Silk (Balt Extru-
sion, Montmorency, France) [7]. A tight mesh of small cell
sizes and a high longitudinal flexibility offer the possibility
to cover an aneurysm orifice. In selected cases, flow
diverters may also be used successfully to reconstruct
intracranial vessel dissections.
In 2010, two different flow diverter devices met the
requirements of the Medical Devices Directive and were
available with CE mark (Silk, Balt Extrusion, Montmorency,
France; Pipeline Embolization Device, PED, ev3, Irvine, CA,
USA). In this study, we sought to evaluate our initial
experience with the PED in a series of 88 patients with 101
treated intracranial vascular lesions.
Material and methods
Pipeline embolization device
The PED used in this series is a composite braided mesh tube
of 48 strands with 75% cobalt chromium and 25% platinum.
T h es i n g l ew i r eh a sad i a m e t e ro f3 0μm. Devices are
available with a nominal diameter from 2.5 to 5 mm with
0.25 mm increments. The nominal length of the implants is in
the range from 10 to 35 mm in 2 mm incrementsfor the 10- to
20-mm lengths and in 5 mm increments for the 25- to 35-mm
lengths. At the nominal diameter, the pore size is 0.02–
0.05 mm
2 and the radial force is about 2.0 mN/mm (3.0 mm
vessel diameter), which is similar to a Silk stent. The braided
wires are loose on both ends. The PED is premounted on a
stainless steel wire and is attached distally to a capture coil.
A radiopaque 15-mm platinum tip extends beyond the end of
the PED. Both the guide wire and the PED are inserted via a
0.027-in. ID microcatheter (Marksman, ev3, Irvine, CA,
USA). Once the PED has reached the desired position,
deployment starts by gently withdrawing the Marksman
catheter and simultaneously advancing the insertion wire.
Expansion of the PED results in gradual foreshortening
which pulls the distal end of the device out of the capture
coil. As soon as the distal end of the PED is detached from
the capture coil, further deployment is a combination of
advancing the insertion wire and passive backward migration
of the microcatheter. Since the density of vessel wall
coverage is largely dependent on the sizing of the implant,
accurate vessel diameter measurement is mandatory. Over-
sizing the device will result in decreased wall coverage and
reduced hemodynamic effect. Based on previous reports and
on our own experience, several PEDs may be required to
achieve a significant hemodynamic effect.
Selection criteria and patient population
A total of 88 patients with 101 intracranial lesions were
treated with the PED between September 2009 and January
2011 in a single neurovascular center. During this period,
94 aneurysms were treated microsurgically in our institu-
tion. Ninety-six aneurysms were treated with PED, and a
total of 195 conventional (i.e., coils and/or stents) endo-
vascular aneurysm procedures were performed. Treatment
decision was based on clinical and anatomical considerations
and oninterdisciplinary discussionbetween the neurovascular
team members. Only unruptured aneurysms or remnants of
previously treated aneurysms were considered for PED
treatment due to the medical platelet antiaggregation therapy
required. Indications for treatment with the PED were wide
neck, aneurysms with a high likelihood of failure with
conventional endovascular or surgical techniques, remnants
of aneurysms after surgical or endovascular treatment,
fusiform aneurysms, and dissected vessels.
Patients were not selected according to age or other
demographic factors. An absolute exclusion criterion for
PED treatment was acute aneurysm rupture. Relative
exclusion criteria were anticipated ease of either microsur-
gical or conventional endovascular treatment, severe elon-
gation of the supraaortic vessels, and confirmed intolerance
or resistance to clopidogrel and/or acetylsalicylic acid
(ASA).
Clinical presentation and lesion morphology
Of the 101 treated lesions, 61 (60%) were found inciden-
tally, 18 (18%) were detected due to a previous subarach-
noid hemorrhage (SAH) from the treated or another
aneurysm, 9 (9%) presented with cranial nerve palsy, and
13 (13%) were symptomatic dissections that had caused
either cerebral ischemia or SAH.
The series comprises 63 (62%) saccular aneurysms, 33
(33%) fusiform aneurysms, and 5 (5%) dissections. The mean
fundus diameter of the 63 saccular aneurysms was 3.8 mm
(range, 2.0 to 15.0 mm; standard deviation, 2.9 mm) and the
mean diameter of the aneurysm neck was 3.3 mm (range, 2.0
to 15.0 mm; standard deviation, 2.4 mm). Of the 63 saccular
aneurysms treated in this series, the largest fundus diameter
was<5mminn=49,5–10 mm in n=11, and >10 mm in n=3
aneurysms. The mean diameter of the parent artery proximal
to the aneurysm was 4.0 mm (range, 2.0–7.0 mm; standard
deviation, 1.0 mm) and the parent artery distal from the
aneurysm had a mean diameter of 3.3 mm (range, 2.0–
5.0 mm; standard deviation, 0.7 mm). In patients with a
diameter >5 mm of the target vessel adjacent to the target
lesion, the “landing zone” of the proximal end of the PED
was intentionally extended more proximally in order to
provide dense wall apposition and avoid an “endoleak”.
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anterior circulation and 22(22%) werelocated inthe posterior
circulation. In the anterior circulation, 6 out of 74 aneurysms
(saccular and fusiform aneurysms) were located outside the
dura.
Previous treatment
All previous treatments and/or underlying dissections were
recorded in a patient database.
Clinical presentation and follow-up
The clinical course of each patient was evaluated according
to the modified Rankin Scale (mRS) before treatment, at
discharge, and at each follow-up angiography (scheduled
for 3 and 6 months after the initial treatment).
Endovascular procedure
The primary intention of every procedure was complete
coverage across the entire length of the dilated or dissected
vessel segment with the PED(s). Procedures were performed
on a biplane flat panel digital subtraction angiography (DSA)
unit (Allura Xper 20/10, Philips, Einthoven, The Nether-
lands; Axiom Artis, Siemens, Erlangen, Germany).
All procedures were carried out under general anesthesia.
Patients received a loading dose of 500 mg ASA and
600 mg clopidogrel at least 1 day prior to the treatment and
a dual antiplatelet treatment with 100 mg ASA and 75 mg
clopidogrel daily thereafter. Each patient was tested for
proper response to ASA and clopidogrel with either Verify
Now® or Multiplate®. Only one patient was found to be
nonresponder to clopidogrel and was given prasugrel
instead. The patient tolerated the procedure well despite
the need to treat with five PEDs. An intravenous bolus of
heparin (5,000 IU) and 500 mg ASA were given at the
beginning of the procedure. Activated clotting time was not
routinely measured. All procedures were carried out or
supervised by the senior author.
The parent artery was catheterized with a 6–F guide
catheter or with a telescoping system of 8 F/6 F distal
access guide catheters. A Marksman microcatheter (ev3,
Irvine, CA, USA) was inserted into the parent artery
distally to the aneurysm with a 0.014- or 0.016-in. micro-
guidewire. The distal end of the microcatheter was
positioned in a straight segment of the parent artery distal
to the target site in order to avoid any vessel injury by the
distal end of the PED delivery system tip wire.
The PED was advanced through the microcatheter and
positioned at the level of the aneurysm. To deploy the
device, the microcatheter was pulled back along with
simultaneous advancement of the insertion wire to keep
the PED in place. The correct expansion of the PED was
documented under fluoroscopy and, in most of the cases,
with additional angiographic computed tomography
(DynaCT).
Postprocedural medication included permanent medica-
tion with 100 mg ASA daily. At the beginning of this series,
75 mg clopidogrel daily were administered for 6 weeks.
After delayed thromboembolic events following flow
diverter treatment had been reported [8], we increased the
duration of clopidogrel medication in March 2010 for at
least 1 year. All patients that had been treated before March
2010 were informed accordingly. The treatment results in
saccular aneurysms were evaluated according to the
O’Kelly–Marotta (OKM) grading scale [9].
Results
The series includes 45 female and 43 male patients with a
mean age of 59 years. Treatment with the PED was
performed in 54 (53%) previously untreated lesions. There
were 30 (30%) lesions that had been previously treated with
laser-cut porous stents, 9 (9%) remnants that had been
previously coiled, and 8 (8%) remnants that had been
previously clipped. Intracranial dissections were treated
with the PED in five patients.
All lesions were successfully accessed in this series, and
successful deployment of the devices was achieved in all
but one procedure (technical success rate, 99%). The failed
attempt was a retreatment of a wide-necked aneurysm of
the internal carotid artery (ICA) located at the origin of the
posterior communicating artery. The PED could not be
placed distally enough due to a major elongation of the
supraaortic vasculature. Since the PED did not cover the
aneurysm completely, the aneurysm was subsequently
covered with an Enterprise stent (Codman, Raynham,
MA, USA).
Balloon dilatation of the target vessel prior to the PED
deployment was performed in eight patients with preexisting
stenosis (Fig. 1). Balloon dilatation after incomplete expan-
sion of the device(s) was carried out in 13 cases. Partial
expansion of the PED was mainly observed in vessel
segments with tight or acute curves (Fig. 2).
More than one PED was implanted (range, 2–18;
median, 3.0) in 67 out of 101 procedures (66%). The
decision to implant more than one device was based on
anatomical circumstances or on the angiographic aspect
after implantation of one or several PEDs (Fig. 3).
Indications for the placement of multiple devices were (1)
unchanged aneurysm perfusion, (2) a deceleration of
contrast circulation within the aneurysm without contrast
stagnation into the venous phase, or (3) specially in cases of
fusiform aneurysms, an incomplete reconstruction of the
Neuroradiology (2012) 54:369–382 371parent artery. According to this strategy, we limited the
procedure to a single device if reduced aneurysm filling or
contrast stagnation was visible until the venous phase,
insinuating a high likelihood of intraaneurysmal thrombo-
sis. Complete aneurysm occlusion immediately after PED
deployment was not observed in any of the patients.
Additional coiling in the same session was performed in
three cases with a microcatheter that was placed within the
Fig. 2 Cavernous aneurysm of the right ICA (a). Poor wall apposition
after deployment of the second PED [2 × 4.5/20] (b). Adaptation of
the PEDs to the vessel wall using a 4 × 15-mm Ascent balloon (c)
results in secondary expansion of the second device with close contact
between its outer surface and the vessel wall (d). Angiographic
follow-up 3 months later shows a decrease of the aneurysm size and a
regular reconstruction of the parent artery (e)
Fig. 1 Fusiform dilatation of the basilar artery with associated
stenosis (a). Preparatory balloon angioplasty (b), followed by PED
deployment [3 × 4.5 × 20, 4.75 × 20, 4.75 × 18, 5.0 × 20, 3.5 × 20,
3.0 × 20] (c). Angiographic follow-up 4 months later shows
remodeling of the dilated vessel (d)
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In these cases, additional coiling was performed since the
effectofflowdiversionwithoutadditionalcoilingwasthought
to be insufficient. We did not observe any clinically relevant
side branch occlusions on post-interventional or follow-up
angiograms among all treated lesions.
Follow-up
Each patient was scheduled for follow-up angiography 3 and
6 monthsafter treatment.The clinicalcondition wasevaluated
accordingtothemRS.Atleast1DSAfollow-upwasavailable
in 80 (91%) patients with 90 (89%) lesions. The mean follow-
up time until the first DSAwas 3 months (range, 1–7 months).
The angiographic follow-up results were classified accord-
ing to the OKM grading scale [9]. This scale accounts for the
amount of aneurysm perfusion and stasis of contrast
medium. Aneurysm perfusion is graded as: A, complete
perfusion (>95%); B, incomplete perfusion (5–95%); C,
neck remnant (>5%); or D, no perfusion (0%). The contrast
medium stagnation grade is determined by the timing of
contrast medium clearance from the aneurysm sac as defined
by the phases of the angiogram: 1, no stasis (clearance within
the arterial phase); 2, moderate stasis (clearance prior to the
venous phase); 3, significant stasis (contrast persists in the
aneurysm into the venous phase and beyond).
Angiographic results according to the OKM grading
scale at the first and last follow-up DSA are shown in
Table 1. Two patients with an occlusion of the target vessel
and one patient with an aneurysm rupture cannot be
classified. There was one de novo aneurysm formation
observed after the treatment of a dissection.
More than one follow-up DSAwas carried out in 41 (47%)
patients and in 49 (49%) lesions. The mean follow-up time to
the lastDSAwas10 months(range, 1–15months).Therewere
three patients with mild, clinically asymptomatic intimal
hyperplasia observed on follow-up angiography.
After 3 months, 90 out of 101 lesions had undergone
follow-up DSA and 47 (52%) out of these 90 lesions were
angiographically occluded. After an average of 10 months,
49 lesions underwent at least a second DSA and 36 of these
49 lesions (74%) were angiographically obliterated, includ-
ing 25 lesions in which the first DSA had already shown
occlusion. Eleven of the 36 (31%) lesions were perfused on
the first follow-up DSA and improved to complete
occlusion until the 10-month follow-up DSA (Fig. 4).
There was no recurrent perfusion once complete oblitera-
tion had been achieved.
Adverse events during the procedure and/or during the
follow-up occurred in 1 out of 54 treatments (2%) without a
previous stent placement and in 4 out of 30 treatments
(13%) in whom a PED was deployed inside another stent.
The observed occlusion rate was 69% and 65% for
aneurysms without and with another stent, respectively.
Fig. 3 Deployment of 19 PEDs in a patient with large aneurysms of
the right ICA, presenting with diplopia and severe headache. Injection
of the right ICA after direct puncture shows fusiform aneurysms of the
petrous and cavernous segments separated by a relative stenosis (a).
Reconstruction of the vessel with 19 PEDs after preparatory balloon
angioplasty (b). MRI 3 days later shows thrombosis of both
aneurysms. In the meantime, the patient has improved clinically
Volume of contrast filling Degree of stasis
1, no stasis 2, moderate stasis 3, significant stasis
A, complete {n=8 (9%)} {n=1 (1%)} {n=2 (2%)}
[N=1 (2%)] [N=0 (0%)] [N=1 (2%)]
B, subtotal {n=9 (10%)} {n=4 (5%)} {n=8 (9%)}
[N=3 (6%)] [N=1 (2%)] [N=3 (6%)]
C, entry remnant {n=4 (5%)} {n=3 (3%)} {n=1 (1%)}
[N=3 (6%)] [N=1 (2%)] [N=0 (0%)]
D, no filling {n=47 (52%)}
[N=36 (74%)]
Occlusion of target vessel n=2 (2%)
Aneurysm rupture n=1 (1%)
Table 1 Angiographic
follow-up results after PED
treatment: volume of contrast
filling of the aneurysm and
degree of stasis of contrast
material at the {first} and [last]
follow-up DSA according to the
OKM grading scale
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Table 2 summarizes the clinical pre- and post-interventional
status in a 3-month period according to the mRS. Clinical
impairment prior to discharge occurred in six patients (6%)
and was due to:
– bleeding from the treated aneurysm (one patient),
– thrombo-embolic events (two patients),
– hemorrhage in the vasculature distal to the target vessel
(two patients),
– gastrointestinal bleeding after the procedure (one
patient).
Technical complications without clinical sequels were
encountered in three procedures. The rates of procedure-
related morbidity and mortality in the entire series to date
(January 2011) are 4% (four patients) and 2% (two
patients), respectively. The procedural complication rate
and the occlusion rate during follow-up for saccular
aneurysms with a fundus diameter <5 mm was 2% and
86%, respectively.
Retreatment
A second PED treatment was carried out in eight patients
(9%). The reason for a second treatment session in all
patients was the persistent or unchanged aneurysm perfu-
sion on follow-up angiography and one de novo aneurysm
formation after the treatment of a dissection of the ICA.
Illustrative cases
Patients are numbered according to the date of their first
treatment. These numbers will be used here and elsewhere.
Patient 5 This 74-year-old female patient presented with
symptoms of brainstem compression due to a large fusiform
aneurysm of the basilar trunk. Immediately after the
deployment of two PEDs (3×18 mm), contrast stagnation
was observed within the aneurysm. The follow-up DSA
performed 8 months after the treatment demonstrated an
incomplete occlusion of the aneurysm, with a well-
reconstructed lumen of the basilar artery and patent anterior
inferior cerebellar arteries (AICAs). At 13 months, reperfu-
Fig. 4 Progressive vessel remodeling after flow diversion. Injection of the left ICA with a paraophthalmic aneurysm (a). Deployment of three
PEDs induced contrast stagnation in the aneurysm (b). After 4 months, complete obliteration of the aneurysm was confirmed (c)
mRS Pretreatment (N=88) At discharge (n=88) 90 days (n=80) Last follow-up (n=41)
0 64 (73%) 63 (71%) 63 (79%) 36 (88%)
1 14 (16%) 11 (13%) 7 (9%) 2 (6%)
2 8 (9%) 7 (8%) 2 (3%) 0 (0%)
3 0 (0%) 0 (0%) 1 (1%) 1(2%)
4 2 (2%) 4 (5%) 5 (6%) 1 (2%)
5 0 (0%) 1 (1%) 1 (1%) 0 (0%)
6 0 (0%) 2 (2%) 1 (1%) 1 (2%)
Table 2 Clinical status before
and after PED treatment
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flow coming from the right vertebral artery (VA), creating
turbulent flow around the outer surface of the PEDs. The
right V4 segment was, therefore, occluded with coils. On
day 1 post treatment, the patient suffered a severe cerebellar
hemorrhage, from which she recovered completely (Fig. 5).
Patient 33 This 56-year-old female patient with a history
of SAH had previously been treated surgically for several
aneurysms, including clipping of a paraclinoid aneurysm
of the right ICA. Angiographic follow-up showed,
among others, four wide-necked aneurysms in the para-
clinoid and supraclinoid segment of the elongated right
ICA. Surgical retreatment and coil occlusion were
considered difficult due to the previous operation, vessel
elongation and aneurysm geometry. After the coaxial
deployment of two PEDs (2.5×20 mm), DSA showed
stasis of contrast material in the aneurysms. DynaCT
confirmed the full expansion of the PEDs. Complete
exclusion of the four aneurysms with reconstruction of
the lumen of the right ICA was confirmed at the first
follow-up DSA after 4 months (Fig. 6).
Complications
Severe procedural complications were encountered in six
patients:
Patient 2: massive intraventricular hemorrhage (IVH)
on the third day after combined PED and coil treatment
of a wide-necked paraclinoid aneurysm
Fig. 5 Large fusiform aneurysm of the basilar trunk with brainstem
compression (a). Contrast stagnation within the aneurysm after PED
deployment [2 × 3/18 mm] (b). Shrinkage of the aneurysm 8 months
later with preserved AICAs (c). Reperfusion and recurrent growth of
the fusiform aneurysm 11 months after the treatment (d) induced by
flow coming from the right VA. Coil occlusion of the right V4
segment (e). Cerebellar hemorrhage 1 day after coil occlusion treated
conservatively (f)
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after the treatment
Patients 18 and 34: intracerebral hemorrhages related
to the dependent vasculature of the target vessel
following otherwise unremarkable PED procedures
Patient 5: cerebellar hemorrhage 14 months after PED
treatment of a fusiform basilar trunk aneurysm with the
PED reaching into the left vertebral artery, 1 day
following the coil occlusion of a right vertebral artery,
which prevented the complete vessel remodeling
Patient 2 (female, 61 years old) had a large wide-necked
paraclinoid aneurysm (fundus, 14 mm; neck, 11 mm) of the
left ICA which had caused a visual field loss. The parent
artery was reconstructed with three telescoping PEDs in
one treatment session with additional loose coiling of the
aneurysm via a “jailed” microcatheter. A significant
contrast medium stasis was observed on the final DSA
run. The patient showed no neurologic impairment directly
after this treatment and was discharged 3 days later.
Heparinization was stopped at discharge. One day later,
she complained of severe headache and an increasing visual
field loss. Computed tomography showed a massive IVH.
DSA on the same day (day 3 after the treatment) showed
the previously treated aneurysm with a neck remnant while
the aneurysm fundus was occluded by coils and thrombus.
A small amount of contrast medium was found adjacent of
the coil occluded dome of the aneurysm and was
considered to be the site of rupture. The patient died 5 days
later (Fig.7).
Patient 15 (male, 44 years old) initially presented with an
intracerebral hemorrhage from a large, partially thrombosed,
dissecting aneurysm originating from the right M1 segment.
Theparentarterywasstraightenedandreinforcedbycoaxially
deployinganEnterpriseandaSolitairestentinJune2009.The
subsequent follow-up DSA showed a significant thrombosis
within the aneurysm, which was, however, still partially
perfused. On November 26, 2009, two PEDs [2.5×20 mm,
2.5×18 mm] were deployed within the two previously
implanted stents. The patient received dual platelet antiag-
gregation as described above. On December 1, 2009, 5 days
after the PED procedure, he presented with severe right-sided
headache without a focal neurological deficit. Magnetic
resonance imaging showed several ischemic lesions within
the right middle cerebral artery supply territory and DSA
confirmed the complete occlusion of the right M1 segment.
Fig. 6 Four de novo aneurysms
of the right paraclinoid and
supraclinoid ICA, following mi-
crosurgical clipping of an aneu-
rysm in the same location years
ago (a). Stasis of contrast mate-
rial in the aneurysms after de-
ployment of two PEDs [2 × 2.5/
20 mm] (b). DynaCT confirmed
the full expansion of the PEDs
(c). Obliteration of the four
aneurysms with reconstruction
of the lumen of the right ICA
was confirmed at the first fol-
low-up DSA after 4 months (d)
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neurological deficit (Fig. 8).
Patient 40 (male, 71 years old) was incidentally found to
carry a diffuse dilatation of the basilar artery bifurcation
with a saccular component between the right superior
cerebellar artery (SCA) and posterior cerebral artery (PCA)
origins. Given the (SCA) irregular shape of the dilatation
and in view of the partially saccular aspect, it was
considered a potential source of a future bleeding. On
August 13, 2009, a Solitaire AB stent was inserted into the
left PCA with the proximal end of the stent in the trunk of
the basilar artery. On March 24, 2010, a PED was deployed
from the right PCA, crossing the Solitaire stent at the level
of the basilar bifurcation and extending with the proximal
end into the trunk of the basilar artery. This procedure was
tolerated well and the patient was discharged in his
previous condition. He was told to continue the medication
of ASA and clopidogrel for 6 weeks and to continue with
ASA thereafter. Eight weeks after the treatment and 22 days
after he had stopped the intake of clopidogrel, he was
referred to another hospital and from there with some delay
to us. At admission, the patient was comatose. DSA
showed the PED and the upper basilar artery filled with
thrombus. Given the time interval from clinical onset to
arrival at our hospital, local intraarterial fibrinolysis was not
considered a reasonable option. The attempted mechanical
thrombectomy failed due to access issues, and the patient
died from the sequelae of brainstem infarct 27 days later.
Patient 18 presented with recurrent attacks of severe
headache. A fusiform aneurysm of the left cavernous ICA
was found and treated with a combination of coils, Leo and
coronary stents in April and September 2009. Angiographic
follow-up in December 2009 showed a significant perfusion
of the aneurysm. One PED was deployed, resulting in
stagnation of contrast medium immediately thereafter. On
the evening after this procedure, the patient was found
Fig. 7 Rupture of a wide-necked paraclinoid aneurysm 3 days after
loose coiling and deployment of three PEDs [4/14, 4.25/20, 4.25/14].
Aneurysm prior to treatment (a) and immediately after coiling and
PED implantation with stagnating contrast medium (b). Four days
later, the patient presented severe headache and visual loss. MRI
showed a massive intraventricular hemorrhage (c). DSA confirmed a
neck remnant of the aneurysm with thrombosis of the fundus 3 h later
(d). Late-phase DSA images revealed an accumulation of contrast
medium outside the contour of the aneurysm sac adjacent to the
aneurysm dome (e)
Neuroradiology (2012) 54:369–382 377hypertensive, aphasic, and hemiplegic on her right side. CT
showed a left parietal hematoma. The patient was managed
conservatively and recovered to a level of complete indepen-
dence with a residual expressive aphasia. Further workup
showed an impaired platelet function. The dual antiaggrega-
tion was changed to 50 mg ASA per day and 75 mg
clopidogrel every other day. With this dosage, the Multiplate
test showed a sufficient platelet function inhibition. DSA in
January 2011 showed a complete aneurysm occlusion. Head-
aches had ceased several weeks after the PED treatment.
In patient 34, a large fusiform aneurysm of the basilar
trunk was treated in 2004 and in 2006 by Neuroform stent
deployment and partial coiling. Angiographic follow-up
showed a slow but gradual enlargement of the aneurysm. In
March 2010, three PEDs were coaxially implanted. On the
evening of the treatment day, the patient was hypertensive,
complained of severe headache, and showed hemiataxia.
CT showed a left-sided cerebellar hemorrhage, which was
managed conservatively. The patients’ condition returned to
his previous status. Angiographic follow-up in January
2011 showed a significant reduction of the aneurysm
perfusion.
For patient 5, see the illustrative case above.
Discussion
The goal of aneurysm therapy is to isolate the vessel
dilatation from cerebral circulation and restore physio-
logical blood flow in the parent artery as far as
possible. The characteristic blood flow pattern in
saccular aneurysms is an inflow zone at the distal
aspect of the neck and an outflow zone at the proximal
side. The decline of intraaneurysmal blood circulation
by flow diversion leads to deceleration of intraaneur-
ysmal velocity and increased blood viscosity, resulting
in an intraaneurysmal thrombus formation. Stents,
primarily designed to assist coil occlusion of wide-
necked aneurysms, have shown to influence the intra-
aneurysmal blood flow even when used without coils
[10]. The extent of intraaneurysmal flow reduction
depends on the porosity and the pore density of the
implanted stent(s). Conventional stents have a relatively
low metal surface area coverage [11]. In contrast, the PED
achieves a 30–35% metal surface area coverage [12].
The results of this series demonstrate that the PED can be a
useful device for the treatment of wide-necked, fusiform, and
previously incompletely treated aneurysms. The results in the
Fig. 8 Acute thrombosis of a PED deployed within two previously
implanted self-expanding stents. Dissecting, partially thrombosed
aneurysm of the right M1 segment (a). An Enterprise and a Solitaire
stent were coaxially deployed to enforce the vessel wall and to redirect
blood flow in June 2009. Follow-up DSA showed further but
incomplete thrombosis of the aneurysm (b). Two PEDs [2.5 × 20,
2.5 × 18] were deployed within the two stents (c). Despite dual
antiplatelet antiaggregation, acute thrombosis of PED and stents
occurred 5 days later with significant MCA ischemia but without a
neurological deficit (d, e)
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struction with the PED can be achieved instantaneously.
As with all neuroendovascular technologies, several
aspects need to be considered. These include patient
selection criteria, technical aspects of PED procedures,
recommendations for duration and regimen of platelet
antiaggregation medication and anticoagulation, com-
plication management, prediction of aneurysm occlu-
sion, follow-up schedule, and criteria for eventual
retreatment.
Patient selection
As described above, complete aneurysm occlusion
immediately after the procedure was not observed in
any of the patients. Due to the delay in aneurysmal
occlusion and the need for dual antiplatelet medication,
PED treatment without coiling appears unsuitable for
ruptured aneurysms in the acute phase. The likelihood
of sufficient flow diversion in bifurcation aneurysms
with incomplete coverage of the neck after placement of
a PED is low. The available extrasaccular flow diverters
are designed for side-wall aneurysms. The potential
benefit of bidirectional flow diversion with a “kissing”
implantation of two PEDs or a combination with
conventional stents needs to be determined. Other
techniques (e.g., microsurgical clipping or stent-assisted
coil occlusion) appear preferable for the treatment of
bifurcation aneurysms.
Flow diversion should currently be regarded as an
endovascular treatment option for wide-necked side-wall
and fusiform aneurysms or remnants of previously treated
aneurysms. Since both catheterization and the need of
endosaccular coil placement carries an increased risk of
procedural rupture especially in very small and blister
aneurysms located at curved vessels, flow diverter implan-
tation offers a way to treat such aneurysms without wall
contact, which should reduce the risk of periprocedural
rupture [13]. Patients with an anticipated difficulty or
failure of conventional microsurgical or endovascular
techniques should particularly be considered for PED
treatment.
Technical aspects
Unlike the Silk stent with a significant rate of deployment
issues [14, 15], the PED is relatively easy to deploy. PED
implantation should result in a combination of tight wall
apposition and dense coverage of the target lesion. The
selection of the appropriate diameter and length of the
device is an essential factor. Implantation of an undersized
device may result in poor wall apposition, with the potential
risk of an endoleak-like phenomenon. Placement of a
device that exceeds the diameter of the target artery will
cause poor coverage of the lesion due to an incomplete
compaction of the strands.
An accurate measurement of the target artery diameter
proximal and distal to the lesion is essential for a proper
device selection. The PED is available with a nominal
diameter from 2.5 to 5 mm in 0.25-mm increments. The
diameter of the proximal segment of the target vessel and
the diameter at the origin of the lesion determine the
diameter of the PED. The distal vessel diameter is of minor
importance in this regard. A smaller distal vessel diameter
will, however, prevent full expansion and related foreshort-
ening of the device and might be an argument for the
selection of a shorter PED. Foreshortening of approximate-
ly 50% and possible device shift during deployment must
be kept in mind when choosing the length of the device
[15]. Inadvertent occlusion of normal side branches covered
by a flow diverter has been reported for both Silk [16] and
PED [17]. The reported risk with PED is, however, low
[18]. Our series confirms this finding. Therefore, we use
long devices that guarantee coverage of the entire lesion
with sufficient proximal and distal overhang. If a very wide
aneurysm neck of a diffusely dilated long vessel should be
reconstructed, telescoping several PEDs is a feasible option
[19, 20]. It should be emphasized that, even with 16 PEDs
deployed in one patient from our series, we encountered no
technical issues or side branch occlusions. The PEDs were
deployed in a telescoping way from PCA to VA with about
four to five complete layers at every point of the entire
distance.
To ensure full expansion and wall apposition of the PED,
both the delivery catheter and the insertion wire must be
pushed during the second phase of deployment. This
technique allows compaction of the device strands. This
may, however, be challenging to achieve in elongated
vessels. In the case of sequential coaxial PED implanta-
tions, the microcatheter is reinserted in the previously
deployed PED(s) using its pusher wire. Withdrawing this
wire can be cumbersome if the capture coil on the pusher
wire is not parallel to the longitudinal axis of the micro-
catheter.
A good wall apposition of the PED requires an equal
diameter or at least a gradual diameter change of the
target vessel. In the case of circumscribed stenosis,
especially if the stenosis is high grade and/or eccentric,
a noncompliant balloon angioplasty of the stenotic
segment prior to the PED deployment is recommended.
If the deployed PED shows poor wall apposition for
whatever reason, an adaptation of the PED to the vessel
wall with a compliant balloon may prevent endoleak
and poor hemodynamic device function. Both types of
balloon dilatation may add complexity and risk to the
entire procedure.
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antiaggregation medication and anticoagulation, potential
complications
A certain drawback in the treatment of aneurysms with flow
diverters (and stents) is the need for antiplatelet medication at
a point at which the aneurysm may not yet be excluded from
circulation. SAH under antiplatelet therapy presents severe
treatment challenges and frequently results in a dismal
outcome. For bare metal porous stents, a dual antiplatelet
regimen for 6 weeks followedbymonotherapy issufficient.A
growing amount of literature reports early and delayed
thromboembolic complications after flow diverter treatment.
Based onthese findings, aswellasonour own experience, we
extendedthedurationofdualantiplateletmedicationtoatleast
1 year after treatment or longer until a complete occlusion of
the aneurysm was confirmed.
As described above, we encountered one fatal SAH from
a treated aneurysm and three parenchymal hemorrhages in
the dependent brain territory after PED treatment. The
underlying mechanism of aneurysm hemorrhage after flow
diversion is a matter of controversy. The implantation of a
flow diverter diminishes the intraaneurysmal blood flow.
This hemodynamic effect per se should reduce the risk of
aneurysmal rupture, even though the aneurysm wall is still
exposed to pulsatile perfusion. Several hemodynamic
studies proved the stent-induced reduction of aneurysmal
inflow which leads to changes of the wall shear stress at the
aneurysm dome [21, 22]. These results are based on in vitro
models or induced aneurysms in animals and are potentially
not conferrable to any human anatomic and hemodynamic
situation without restriction. An unfavorable valve mecha-
nism with augmentation of inflow and/or suppression of
outflow has been discussed (“hemodynamic theory”)[ 23].
Another cause of rupture after flow diverter treatment
was discussed by Turowski et al. [24]. The process of
thrombus formation begins with the stagnation of blood
flow, leading to the formation of red thrombus, progressing
to a white thrombus, followed by subsequent thrombus
organization. Red thrombi contain proteolytic enzymes and
leucocytes. A large amount and a prolonged phase of red
thrombus within the aneurysm without progression to an
organized thrombus might promote an inflammatory reac-
tion, eventually resulting in the disintegration of the
aneurysm wall with subsequent rupture (“inflammatory
theory”). The sequence of thrombus formation can be
regulated in different directions by the use of antiplatelet,
anticoagulant, and anti-inflammatory agents. In our patient
2, the SAH occurred 1 day after the heparinization was
stopped. In large saccular aneurysms, the extended admin-
istration of heparin for 6 weeks and steroids for 3 weeks is
recommended and seems to reduce the risk of hemorrhage
after flow diversion.
The additional use of coils in large aneurysms does
neither improve nor disturb the process of aneurysm
obliteration induced by flow diversion [12]. It is currently
undetermined if previous partial coiling or clipping of large
and giant aneurysms can prevent hemorrhage after flow
diversion. Hemorrhagic complications were not encoun-
tered after PED deployment in the 34 pretreated saccular
aneurysms in our series.
The presence of a previously deployed stent may reduce
the hemodynamic effect of a PED [25]. Since delayed
endothelialization has to be expected under these circum-
stances, an extended phase or lifetime-long dual platelet
antiaggregation should be contemplated.
Delayed parenchymal hemorrhage is very rare after
stent-assisted coil occlusion of intracranial aneurysms. We
assume that microemboli (e.g., air) and microinfarcts during
PED deployment may trigger parenchymal bleedings,
which now occur with identical anticoagulation and
antiaggregation protocols.
Prediction of aneurysm occlusion
The goal of endosaccular endovascular treatment of
intracranial aneurysms is complete aneurysm occlusion.
This can be accomplished by dense coil packing. Ideally,
there is no visible contrast medium between the coil loops
on the final angiographic run even though studies showed
that the intrinsic aneurysm occlusion is not exceeding 30%
at this point. The rate of hemorrhages from coiled
aneurysms is low. Nevertheless, several series on the
endovascular coil treatment of aneurysms confirmed a
significant rate of retreatment [26]. The primary aim of
flow diverter treatment of an aneurysm is to induce a
process of intraaneurysmal thrombus formation with the
final goal of complete aneurysm occlusion. Residual or
unchanged aneurysmal filling is the typical finding imme-
diately after placement of a flow-diverting device. The time
frame of this process is probably determined by numerous
factors but finally not predictable [16]. The number of
treated lesions in our series is too small and the material is
too inhomogeneous to allow the identification of lesional or
procedural features predisposing for complete occlusion or
persistent perfusion. Aneurysm size and geometry certainly
play a significant role, assuming that smaller aneurysms
will need a shorter period for complete thrombosis. The
process of thrombosis might be extended in bifurcation
aneurysms due to a clearly vectored inflow direction.
The effect of flow diverter implantation can be estimated
by several angiographic signs that indicate a change of the
intraaneurysmal flow. O’Kelly et al. proposed a grading
scale for the angiographic assessment of intracranial
aneurysms treated with flow diverters. The volume of
contrast filling and the degree of contrast medium stagna-
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elements of this grading scale. The duration of contrast
stasis induced by a flow diverter might be a helpful tool to
estimate the likelihood of complete intraaneurysmal throm-
bosis [9]. This might also help to determine the need of
more than one flow diverter. In our series, more than 1 PED
was used initially in 67 cases. Reasons for the deployment
of multiple PEDs are a synchronous clearance of the parent
artery and the aneurysm after placement of one PED. In
large aneurysms with a minor delay of clearance after one
PED, telescoping PED implantation was performed as well.
There are, however, no definitive criteria when to stop
telescoping PEDs. A single PED was used in cases with
significant stasis of contrast medium up to the venous phase
of the angiogram. This criterion still leaves plenty of space
for error.
O u rs e r i e si n c l u d e s3 0l e s i o n st r e a t e dp r e v i o u s l yw i t h
conventional stents. The assumption of a negative interaction
between a PED and a previously implanted laser-cut porous
stent arises specially with regard to the above-described
complications. This combination of previously placed stents
andPEDsmayimpairthewallappositionandmaypreventthe
process of device endothelialization. This could have been a
factor for the development of thrombotic parent vessel
occlusion in the two above-mentioned patients. The origin
of side branches from vessel dilatations is another factor that
may prevent aneurysm thrombosis and vessel remodeling.
Follow-up schedule and criteria for retreatment
As mentioned above, we schedule the first follow-up
angiographies 3 and 6 months after treatment. As expected
from a series of this size, some patients are lost to follow-up
despite serious efforts to obtain comprehensive follow-up data.
In the case of complete aneurysm occlusion at the
second follow-up angiography and the absence of intimal
hyperplasia within the PED, we advise the patient to
continue with the dual antiplatelet therapy for an additional
6 months.
In patients with unchanged aneurysm perfusion com-
pared to the postprocedural angiogram, we recommend
deployment of additional PED(s). If the involution of the
aneurysm is obviously disturbed by other vessels with
competing flow, we evaluate and eventually perform the
endovascular occlusion of these arteries [27]. The decision
for retreatment was made individually based on the
angiographic findings and the patient’s age and clinical
status. Incompletely coiled or clipped aneurysms will
almost certainly not improve without further treatment,
which makes the decision for retreatment in these cases
relatively easy. Decision-making between retreatment and
observation after flow diversion is more complex since the
process of reverse remodeling after flow diverter treatment
is rather unpredictable. This will hopefully change as soon
as long-term follow-up data become available.
The need for further follow-up angiographies after a
documented complete occlusion of an aneurysm or com-
plete vessel reconstruction after intracranial dissections
remains unclear. A mechanism of aneurysm recurrence
after successful flow diversion is currently not known.
Long-term data that determine the likelihood of recurrent
perfusion after flow diverter treatment are required.
A potential argument for further angiographic follow-up
after complete aneurysm occlusion is the high incidence of
intimal hyperplasia that has been reported for the Silk flow
diverter and for balloon expandable cobalt chromium stents
[15, 28]. The incidence of intimal hyperplasia with PED
might be lower compared to stent-treated intracranial
stenoses, since the PED is mostly implanted without
balloon angioplasty thus avoiding a mechanical vessel
injury. Animal experiments have shown a very low rate of
intimal hyperplasia with PED [18]. Although we did not
observe a single symptomatic intimal hyperplasia in this
small series with a relatively short follow-up period, we
propose our patients to perform follow-up angiographies in
yearly intervals until further data on this issue are available.
Conclusion
Flow diversion using the PED is a technically straightfor-
ward and relatively safe treatment modality for the
treatment of wide-necked saccular side-wall aneurysms,
fusiform aneurysms, remnants of aneurysms after surgical
or endovascular treatment, and dissected vessels in selected
cases. Telescoping several PEDs and balloon adaptation of
the PEDs to the vessel wall is frequently required. Vessel
reconstruction after dissection is achieved within days.
Aneurysm occlusion and vessel remodeling can take
several months. Complications are not frequent but may
include intraparenchymal bleeding into brain areas related
to the target vessel, induced rupture of saccular aneurysms,
and early as well as late acute in-stent thrombosis. An
efficient dual antiaggregation is recommended for 1 year.
Long-term data are still missing to predict the likelihood of
aneurysmal occlusion after flow diverter treatment and to
analyze the frequency of clinically relevant intimal hyper-
plasia within the PED. Flow diversion requires an individ-
ualized treatment strategy including also microsurgical and
endosaccular interventional options and a careful anti-
coagulation–antiaggregation regimen.
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